Guy Wendy 4

What Happened Guy Wendy, Chief Administrative Officer of Processa Pharmaceuticals, reported an acquisition of 1,854 common shares on 2026-03-31. The transaction was an open-market/private purchase (code P) at $2.54 per share for a total of about $4,700. Purchases by insiders are often viewed as a positive signal, though this is a modest-sized buy.

Key Details

• Transaction date and price: 2026-03-31 — 1,854 shares at $2.54 each.
• Total value: approximately $4,700.
• Transaction code: P (purchase; reported as open-market or private purchase).
• Shares owned after the transaction: Not reported in the information provided in this summary.
• Filing timeliness: Reported on 2026-04-01 for a 2026-03-31 transaction — filing appears timely (not noted as late).
• No 10b5-1 plan, tax-withholding, or other footnotes were indicated in the provided data.

Context This is a straightforward insider purchase (not an option exercise, gift, or award). The dollar amount is small relative to many insider trades, so while it shows insider buying, it may not by itself signal a major change in insider conviction.